Higher baseline high-sensitivity C-reactive protein levels were significantly associated with higher depressive symptom scores over three years after mild-to-moderate ischemic stroke (β 1.28).
Cohort (n=585)
Yes
Does elevated baseline hs-CRP associate with increased depressive symptoms over time in patients with mild-to-moderate ischemic stroke?
Elevated baseline hs-CRP levels in patients with mild-to-moderate ischemic stroke are associated with increased depressive symptoms over a 3-year follow-up, particularly in women.
Effect estimate: β 1.28 (95% CI 0.22-2.34)
p-value: p=<0.05
BACKGROUND AND PURPOSE: C-reactive protein serves as a marker of inflammation and is linked to depression in the general population. We aimed to assess whether elevated baseline levels of high-sensitivity C-reactive protein (hs-CRP) are associated with depressive symptoms over time in a prospective cohort of mild-to-moderate first-ever ischemic stroke patients. METHODS: Data were obtained from the Prospective Cohort with Incident Stroke Berlin (NCT01363856). Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) at three annual follow-up points. We assessed the association of elevated levels of hs-CRP with CES-D scores over time via linear mixed models. In a subgroup analysis, we explored an interaction effect with sex. RESULTS: We included 585 ischemic stroke patients with baseline data on CRP levels. The mean age was 67 (13 SD), 39% (n = 226) were female, and the median National Institutes of Health Stroke Scale (NIHSS) was 3 (IQR 1-4). Twenty percent of survivors showed evidence for depressive symptoms one year after stroke with CES-D ≥ 16, 21% at year two, and 17% at year three. Higher log-transformed baseline hs-CRP levels were associated with higher CES-D Scores over time in the adjusted linear mixed model (β = 1.28; (95% CI 0.22-2.34)). The subgroup analysis revealed an interaction effect of hs-CRP on depressive symptoms in women (β = 2.33; (95% CI 0.71-3.95)). CONCLUSION: In our cohort with mild-to-moderate first-ever ischemic stroke patients, hs-CRP levels were associated with more depressive symptoms over time, with an interaction effect for the female sex. STUDY REGISTRATION: https://clinicaltrials.gov ; Unique identifier: NCT01363856.
Schaeff et al. (Wed,) conducted a cohort in Mild to moderate ischemic stroke (n=585). High-sensitivity C-reactive protein (hs-CRP) vs. Lower hs-CRP levels was evaluated on Depressive symptoms over time (CES-D scores) (β 1.28, 95% CI 0.22-2.34, p=<0.05). Higher baseline high-sensitivity C-reactive protein levels were significantly associated with higher depressive symptom scores over three years after mild-to-moderate ischemic stroke (β 1.28).